ClinicalTrials.gg
Status unknownNCT05360940Updated Jul 19, 2022

Concomitant Infection of Intestinal Parasites and Helicobacter Pylori

An observational study in Dyspepsia Abdominal Burning Pain Diarrhea Dysentery, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 1 Year and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-19.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
1 Year and older
Sex
All
01

Study summary

Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in the world especially in developing countries.

Helicobacter pylori is a gram-negative,helical-shaped,motile bacillus bacterium,which colonizes the gastric mucosa.

H.pylori bacterium secretes urease,a special enzyme that converts urea to ammonia.

Ammonia reduces the stomach's acidity .This risk factor allows pathogenic intestinal protozoa such as G.lamblia to take the opportunity to cross through the stomach's increased pH and cause disease.

02

Conditions studied

  • Dyspepsia Abdominal Burning Pain Diarrhea Dysentery

Keywords

  • Helicobacter pylori Intestinal Parasites
03

In context

Diarrhea

877 studies on the registry are indexed under Diarrhea; 76 are open to participants now.

This study's planned enrollment of 200 is below the median of 248 across 103 observational studies indexed under Diarrhea.

Browse Diarrhea studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Samples will be collected from outpatients complaining of dyspepsia, abdominal burning pain, diarrhea,and dysentery with persons of any age or sex groups from different locations (cities and villages)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients complaining of dyspepsia , abdominal burning pain,diarrhea,dysentery,of persons of any age or sex group.

Exclusion criteria

Exclusion Criteria:

  • patients taking antibiotics within the previous four weeks, proton pump inhibitors within the previous two weeks, or anti-parasitic drugs within the previous two weeks.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • A

    100 positive stool samples for H.pylori

    Diagnostic Test: H.pylori stool antigen rapid test and stool parasitological examination

  • B

    100 negative stool samples for H.pylori

    Diagnostic Test: H.pylori stool antigen rapid test and stool parasitological examination

Interventions

  • Diagnostic testH.pylori stool antigen rapid test and stool parasitological examination

    200 stool samples ( 100 positive and 100 negative for H.pylori) after performance of H.pylori stool rapid antigen test then parasitological stool examination will be done

06

What researchers measure

Primary outcomes

  1. Compare the prevalence of intestinal parasitic infections among positive and negative H.pylori infected outpatients in Sohag University Hospital

    Collection of 200 stool samples (100 positive and 100 negative for H.pylori) then parasitological examination done for all samples

    Time frame: 18 weeks following the start point of the study

Secondary outcomes

  1. Evaluate the prevalence of intestinal parasitic infection among H.pylori infected outpatients in Sohag University Hospital

    Macroscopic and microscopic examination of 100 positive H.pylori stool samples

    Time frame: 18 weeks following the start point of the study

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05360940
Lead sponsor
Sohag University
Responsible party
Asmaa Nabil Abouzeid (Demonstrator at medical parasitology department at faculty of medicine Sohag university, Sohag University) — Principal investigator
First posted
May 4, 2022
Start date
Sep 2022 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Jul 2023 (estimated)
Last update
Jul 19, 2022

Study contacts

Asmaa Nabil Abouzeid
Contact
asmaanabil@med.sohag.edu.eg
01144306719

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion